--2025/Q2-- / 419.800M--
--2024/Q4-- / 390.800M--
--2023/Q2120.700M / ----
--2022/Q480.749M / 68.850M--
--2022/Q355.300M / ----
US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 15.350
- +0.200+1.32%
Close Nov 26 16:00 ET
5.40BMarket Cap168.68P/E (TTM)
15.610High15.110Low14.78KVolume15.330Open15.150Pre Close226.79KTurnover0.09%Turnover Ratio1535.00P/E (Static)351.68MShares19.99052wk High20.63P/B260.95MFloat Cap14.44052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM3.30%Amplitude14.440Historical Low15.343Avg Price1Lot Size
Telix Pharmaceuticals Key Stats
Telix Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: AUD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data